Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of CETP inhibition with evacetrapib in patients with diabetes mellitus enrolled in the ACCELERATE trial.
Menon V, Kumar A, Patel DR, St John J, Riesmeyer J, Weerakkody G, Ruotolo G, Wolski KE, McErlean E, Cremer PC, Nicholls SJ, Lincoff AM, Nissen SE. Menon V, et al. Among authors: st john j. BMJ Open Diabetes Res Care. 2020 Mar;8(1):e000943. doi: 10.1136/bmjdrc-2019-000943. BMJ Open Diabetes Res Care. 2020. PMID: 32179516 Free PMC article. Clinical Trial.
Factors underlying regression of coronary atheroma with potent statin therapy.
Puri R, Nissen SE, Ballantyne CM, Barter PJ, Chapman MJ, Erbel R, Libby P, Raichlen JS, St John J, Wolski K, Uno K, Kataoka Y, Nicholls SJ. Puri R, et al. Among authors: st john j. Eur Heart J. 2013 Jun;34(24):1818-25. doi: 10.1093/eurheartj/eht084. Epub 2013 May 3. Eur Heart J. 2013. PMID: 23644179 Clinical Trial.
Atheroma progression in hyporesponders to statin therapy.
Kataoka Y, St John J, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ. Kataoka Y, et al. Among authors: st john j. Arterioscler Thromb Vasc Biol. 2015 Apr;35(4):990-5. doi: 10.1161/ATVBAHA.114.304477. Epub 2015 Feb 26. Arterioscler Thromb Vasc Biol. 2015. PMID: 25722430
Favorable Impact on LDL Particle Size in Response to Treatment With Pioglitazone is Associated With Less Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes.
Mani P, Uno K, St John J, Kupfer S, Perez A, Tuzcu EM, Hazen SL, Nissen SE, Nicholls SJ. Mani P, et al. Among authors: st john j. J Am Coll Cardiol. 2015 Jul 21;66(3):328-329. doi: 10.1016/j.jacc.2015.05.023. J Am Coll Cardiol. 2015. PMID: 26184626 Free article. Clinical Trial. No abstract available.
Implications of Total to High-Density Lipoprotein Cholesterol Ratio Discordance With Alternative Lipid Parameters for Coronary Atheroma Progression and Cardiovascular Events.
Elshazly MB, Nicholls SJ, Nissen SE, St John J, Martin SS, Jones SR, Quispe R, Stegman B, Kapadia SR, Tuzcu EM, Puri R. Elshazly MB, et al. Among authors: st john j. Am J Cardiol. 2016 Sep 1;118(5):647-55. doi: 10.1016/j.amjcard.2016.06.021. Epub 2016 Jun 15. Am J Cardiol. 2016. PMID: 27392507
Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.
Puri R, Nissen SE, Arsenault BJ, St John J, Riesmeyer JS, Ruotolo G, McErlean E, Menon V, Cho L, Wolski K, Lincoff AM, Nicholls SJ. Puri R, et al. Among authors: st john j. JAMA Cardiol. 2020 Oct 1;5(10):1136-1143. doi: 10.1001/jamacardio.2020.2413. JAMA Cardiol. 2020. PMID: 32639518 Free PMC article. Clinical Trial.
503 results